Taiwan FDA registration 0f56292060cd240eb270d1c9361fdfad
“Aurum” Blood Glucose Control Solution(Non-Sterile)
TW: “瑞瑩”血糖品管液(未滅菌)
Taiwan·Risk Class 1·MD·AURUM BIOMEDICAL TECHNOLOGY, INC.·Registered Sep 02, 2021 – Sep 02, 2026ActiveRegistration details
- Analysis ID
- 0f56292060cd240eb270d1c9361fdfad
- License Form
- Ministry of Health Medical Device Manufacturing No. 009285
Company information
- Manufacturer
- AURUM BIOMEDICAL TECHNOLOGY, INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- AURUM BIOMEDICAL TECHNOLOGY, INC.
Product details
- Intended Use
- Limited to the classification and grading management of medical equipment, quality control materials (analytical and non-analytical) (A.1660) the first level identification range.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1660 Quality Control Materials (Analytical and Non-Analytical)
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Sep 02, 2021
- Expiry Date
- Sep 02, 2026
About this record
Access comprehensive regulatory information for “Aurum” Blood Glucose Control Solution(Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 0f56292060cd240eb270d1c9361fdfad and manufactured by AURUM BIOMEDICAL TECHNOLOGY, INC.. The authorized representative in Taiwan is AURUM BIOMEDICAL TECHNOLOGY, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices